\-\ Texto\\:\\ \ \(0\)\
\-\ myelomeningocele\\ \\-\\ open\\ defect\\ of\\ spinal\\ canal\\ with\\ myelomeningocele\\ in\\ sacral\\ region\\ noted\\ at\\ birth\\.\ \(0\)\
\-\ close\\ follow\\ up\\ with\\ urology\\,\\ and\\ serial\\ vcug\\ \\(every\\ one\\ to\\ two\\ years\\)\\ and\\ renal\\ ultrasounds\\.\\ \\ patient\\ is\\ at\\ risk\\ for\\ developing\\ secondary\\ vesicoureteral\\ reflux\\ and\\ a\\ small\\,\\ high\\ resistance\\ bladder\\ requiring\\ surgical\\ bladder\\ augmentation\\.\ \(0\)\
\-\ bladder\\ with\\ persistently\\ funnel\\-shaped\\ bladder\\ neck\\ during\\ filling\\ on\\ vcug\\ with\\ mild\\ trabeculations\\ of\\ bladder\\ wall\\.\\ \\ \ \(0\)\
\-\ mri\\ demonstrates\\ sacral\\ myelomeningocele\\ with\\ sacral\\ posterior\\ midline\\ defect\\ and\\ protruding\\ spinal\\ cord\\ and\\ meninges\\.\\ also\\ the\\ posterior\\ fossa\\ is\\ small\\ and\\ the\\ foramen\\ magnum\\ is\\ widened\\ consistent\\ with\\ chiari\\ ii\\ malformation\\.\ \(0\)\
\-\ myelomeningocele\\,\\ neurogenic\\ bladder\ \(0\)\
\-\ neurogenic\\ bladder\ \(10\)\
\-\ myelomeningocele\ \(20\)\
\-\ meningocele\ \(49\)\
\-\ term\\ female\\ infant\\ with\\ myelomeningocele\ \(0\)\
\-\ this\\ patient\\'s\\ myelomeningocele\\ had\\ been\\ surgically\\ corrected\\ and\\ she\\ was\\ undergoing\\ initial\\ work\\ up\\ for\\ neurogenic\\ bladder\\ by\\ pediatric\\ urology\\.\\ the\\ vcug\\ shows\\ early\\ findings\\ of\\ neurogenic\\ bladder\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myelomeningocele\\:\\ 0\\.29154133170558866\ \(0\)\
\-\ bladder\\:\\ 0\\.20536643446869252\ \(0\)\
\-\ neurogenic\\:\\ 0\\.1384255358546601\ \(0\)\
\-\ vcug\\:\\ 0\\.10894108338083228\ \(0\)\
\-\ sacral\\:\\ 0\\.10118366387866898\ \(0\)\
\-\ urology\\:\\ 0\\.06959418288618864\ \(0\)\
\-\ funnel\\-shaped\\:\\ 0\\.05799683173662169\ \(0\)\
\-\ trabeculations\\:\\ 0\\.0507691193111736\ \(0\)\
\-\ persistently\\:\\ 0\\.04519479128231042\ \(0\)\
\-\ defect\\:\\ 0\\.04208878060920956\ \(0\)\
\-\ ultrasounds\\:\\ 0\\.0406346124628371\ \(0\)\
\-\ augmentation\\:\\ 0\\.0406346124628371\ \(0\)\
\-\ meningocele\\:\\ 0\\.0406346124628371\ \(0\)\
\-\ spinal\\:\\ 0\\.04026021329446824\ \(0\)\
\-\ protruding\\:\\ 0\\.03935727026256764\ \(0\)\
\-\ meninges\\:\\ 0\\.03935727026256764\ \(0\)\
\-\ corrected\\:\\ 0\\.03898122806625219\ \(0\)\
\-\ resistance\\:\\ 0\\.03796707885686233\ \(0\)\
\-\ magnum\\:\\ 0\\.036074433643363775\ \(0\)\
\-\ chiari\\:\\ 0\\.03499349251644748\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.03442104924677887\ \(0\)\
\-\ widened\\:\\ 0\\.033406900037389005\ \(0\)\
\-\ requiring\\:\\ 0\\.031060354353581565\ \(0\)\
\-\ up\\:\\ 0\\.03023483093492399\ \(0\)\
\-\ every\\:\\ 0\\.029860870427305543\ \(0\)\
\-\ developing\\:\\ 0\\.029419164487584304\ \(0\)\
\-\ surgically\\:\\ 0\\.02846632930417341\ \(0\)\
\-\ serial\\:\\ 0\\.028037115344512878\ \(0\)\
\-\ undergoing\\:\\ 0\\.027569379017646226\ \(0\)\
\-\ close\\:\\ 0\\.02744162845279688\ \(0\)\
\-\ pediatric\\:\\ 0\\.027072618803776854\ \(0\)\
\-\ birth\\:\\ 0\\.027013080412198447\ \(0\)\
\-\ foramen\\:\\ 0\\.02683763141823686\ \(0\)\
\-\ infant\\:\\ 0\\.026610748680926534\ \(0\)\
\-\ work\\:\\ 0\\.026337724135487368\ \(0\)\
\-\ reflux\\:\\ 0\\.025973578773098128\ \(0\)\
\-\ posterior\\:\\ 0\\.02591629669345327\ \(0\)\
\-\ small\\:\\ 0\\.02590230637343577\ \(0\)\
\-\ term\\:\\ 0\\.02572528714163203\ \(0\)\
\-\ open\\:\\ 0\\.02498841175757614\ \(0\)\
\-\ ii\\:\\ 0\\.024247498085812003\ \(0\)\
\-\ fossa\\:\\ 0\\.022913155465139005\ \(0\)\
\-\ filling\\:\\ 0\\.022633158001857452\ \(0\)\
\-\ malformation\\:\\ 0\\.022423333240173548\ \(0\)\
\-\ canal\\:\\ 0\\.022335417267725078\ \(0\)\
\-\ midline\\:\\ 0\\.021750855837753425\ \(0\)\
\-\ cord\\:\\ 0\\.021362986317140797\ \(0\)\
\-\ early\\:\\ 0\\.020560256379226562\ \(0\)\
\-\ risk\\:\\ 0\\.02036320162736241\ \(0\)\
\-\ initial\\:\\ 0\\.018628829889995445\ \(0\)\
\-\ follow\\:\\ 0\\.017863154420700224\ \(0\)\
\-\ during\\:\\ 0\\.017204008223182948\ \(0\)\
\-\ renal\\:\\ 0\\.01689128650959256\ \(0\)\
\-\ years\\:\\ 0\\.01650817853301633\ \(0\)\
\-\ neck\\:\\ 0\\.01650817853301633\ \(0\)\
\-\ wall\\:\\ 0\\.016283941580518067\ \(0\)\
\-\ two\\:\\ 0\\.016100863405368458\ \(0\)\
\-\ region\\:\\ 0\\.0158789554423639\ \(0\)\
\-\ she\\:\\ 0\\.015781487772724815\ \(0\)\
\-\ secondary\\:\\ 0\\.015717302411242154\ \(0\)\
\-\ shows\\:\\ 0\\.015456405919268938\ \(0\)\
\-\ high\\:\\ 0\\.015385171454452734\ \(0\)\
\-\ been\\:\\ 0\\.015294703220157836\ \(0\)\
\-\ one\\:\\ 0\\.015235074890201605\ \(0\)\
\-\ at\\:\\ 0\\.015233725695153065\ \(0\)\
\-\ mild\\:\\ 0\\.014804299039020637\ \(0\)\
\-\ consistent\\:\\ 0\\.01378485703178423\ \(0\)\
\-\ noted\\:\\ 0\\.01332513939771443\ \(0\)\
\-\ mri\\:\\ 0\\.01291628851917513\ \(0\)\
\-\ \\'s\\:\\ 0\\.012395043541888454\ \(0\)\
\-\ demonstrates\\:\\ 0\\.01228040264245517\ \(0\)\
\-\ had\\:\\ 0\\.012130590916057291\ \(0\)\
\-\ \\-\\:\\ 0\\.012050845123081338\ \(0\)\
\-\ findings\\:\\ 0\\.011966032472302365\ \(0\)\
\-\ surgical\\:\\ 0\\.011817248488496404\ \(0\)\
\-\ female\\:\\ 0\\.011557633364788378\ \(0\)\
\-\ patient\\:\\ 0\\.011270946459426157\ \(0\)\
\-\ is\\:\\ 0\\.011097844310224847\ \(0\)\
\-\ also\\:\\ 0\\.011083023642566785\ \(0\)\
\-\ for\\:\\ 0\\.009593528271614672\ \(0\)\
\-\ by\\:\\ 0\\.009360992784505754\ \(0\)\
\-\ and\\:\\ 0\\.00828988842187848\ \(0\)\
\-\ was\\:\\ 0\\.006501825804037413\ \(0\)\
\-\ this\\:\\ 0\\.0063232711402245595\ \(0\)\
\-\ with\\:\\ 0\\.005388350214665974\ \(0\)\
\-\ \\,\\:\\ 0\\.005342961819420146\ \(0\)\
\-\ on\\:\\ 0\\.004762440870825184\ \(0\)\
\-\ \\(\\:\\ 0\\.004752379777920135\ \(0\)\
\-\ \\)\\:\\ 0\\.004694326921798059\ \(0\)\
\-\ to\\:\\ 0\\.002809658608177541\ \(0\)\
\-\ in\\:\\ 0\\.0027723501982911507\ \(0\)\
\-\ the\\:\\ 0\\.0027286043033610354\ \(0\)\
\-\ a\\:\\ 0\\.002609209222490798\ \(0\)\
\-\ of\\:\\ 0\\.0022994171210129295\ \(0\)\
\-\ \\.\\:\\ 0\\.0018683966367024354\ \(0\)\
